Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05444049 · ClinicalTrials.gov registry record · NA
NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE)
A NA study of Cardiovascular Diseases and Cardiac Arrest, sponsored by neurescue.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT05444049 is a NA study of Cardiovascular Diseases and Cardiac Arrest that has completed, run by neurescue. The registered enrollment target is 6 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05444049, a NA study of Cardiovascular Diseases and Cardiac Arrest, has completed, sponsored by neurescue.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The NEURESCUE device is the first intelligent catheter for aortic balloon occlusion, an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The catheter-based device is delivered via the femoral artery, temporarily inflating a soft balloon in the descending aorta to redirect blood flow towards the upper body. The objective of this study is to investigate the feasibility of the NEURESCUE device as an adjunct to Advanced Cardiac Life Support (ACLS) in adults with cardiac arrest.
Conditions Studied
Interventions
- DEVICE NEURESCUE device
Study Locations (1)
California
- Long Beach Medical Center - Long Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2022-12-08 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05444049
The ClinicalTrials.gov registry entry for NCT05444049 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is neurescue, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which NEURESCUE device is the first listed.
NCT05444049 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05444049 about?
NCT05444049 is a clinical study titled "NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE)". The NEURESCUE device is the first intelligent catheter for aortic balloon occlusion, an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The catheter-based device is delivered via the femoral artery, temporarily inflating a soft balloon in t...
What is the current status of trial NCT05444049?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2022-12-08. Estimated completion is 2024-09-30.
What conditions does trial NCT05444049 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Cardiac Arrest, Cardiopulmonary Arrest.
What interventions are being tested in trial NCT05444049?
The interventions under investigation include: NEURESCUE device (DEVICE).
Who is sponsoring clinical trial NCT05444049?
This trial is sponsored by neurescue, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05444049 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.